S.C. Ropharma S.A. (BVB:RPH)

S.C. Ropharma Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.15	19.9	16.51	15.42	10.66	14.66
Cash & Short-Term Investments	23.15	19.9	16.51	15.42	10.66	14.66
Cash Growth	-28.71%	20.52%	7.06%	44.70%	-27.28%	27.25%
Accounts Receivable	344.7	323.12	252.48	258.74	204.33	208.8
Other Receivables	7.5	9.83	11.39	10.07	18.68	10.58
Receivables	352.2	332.96	263.88	268.81	223.01	219.38
Inventory	219.99	227.41	170.06	159.79	130.2	114.72
Prepaid Expenses	3.27	1.47	1.42	1	1.06	0.81
Other Current Assets	24.82	19.85	0.17	0.38	0.17	10.12
Total Current Assets	623.44	601.6	452.05	445.4	365.09	359.69
Property, Plant & Equipment	272.48	270.62	288.14	259.76	243.25	235.15
Long-Term Investments	0	0	0	0	0	0.15
Goodwill	23.86	23.86	23.86	23.86	23.86	24.31
Other Intangible Assets	41.46	35.85	30.13	28.13	22.7	21.58
Other Long-Term Assets	14.46	15.83	13.6	13.1	12.43	10.3
Total Assets	975.7	947.76	807.78	770.25	667.34	651.17
Accounts Payable	507.09	497.19	365.49	363.9	290.03	289.08
Accrued Expenses	15.23	7.99	11.28	10.64	9.36	4.23
Short-Term Debt	39.33	36.35	38.5	38.81	33.99	39.9
Current Portion of Long-Term Debt	6.62	8.93	14.92	12.21	13.53	15.3
Current Portion of Leases	12.58	11.25	10.85	10.86	9.45	8.69
Current Income Taxes Payable	4.23	4.13	-	0.62	0.54	0
Current Unearned Revenue	0.49	4.83	0.84	0.19	0.25	0.27
Other Current Liabilities	8.98	0.26	3.68	4.13	2.78	0.9
Total Current Liabilities	594.54	570.93	445.55	441.36	359.93	358.38
Long-Term Debt	22.65	22.5	17.02	26.22	27.34	35.72
Long-Term Leases	86.66	83.4	82.79	60.18	52.49	46.36
Long-Term Deferred Tax Liabilities	11.13	11.59	10.56	9	7.99	8.83
Other Long-Term Liabilities	-0	-	-0	-0	-0	0
Total Liabilities	714.98	688.42	555.92	536.76	447.75	449.29
Common Stock	51.13	51.13	51.13	51.13	51.13	51.13
Additional Paid-In Capital	2.02	2.02	2.02	2.02	2.02	2.02
Retained Earnings	135.01	135.44	135.55	135.6	56.73	49.35
Treasury Stock	-	-	-	-	-0.13	-0.15
Comprehensive Income & Other	55.67	56.64	51.39	42.84	102.72	95.52
Total Common Equity	243.82	245.23	240.08	231.59	212.47	197.87
Minority Interest	16.9	14.12	11.77	1.91	7.12	4
Shareholders' Equity	260.72	259.34	251.85	233.49	219.59	201.87
Total Liabilities & Equity	975.7	947.76	807.78	770.25	667.34	651.17
Total Debt	167.83	162.42	164.08	148.28	136.79	145.98
Net Cash (Debt)	-144.68	-142.52	-147.57	-132.86	-126.13	-131.32
Net Cash Per Share	-0.28	-0.28	-0.29	-0.26	-0.25	-0.26
Filing Date Shares Outstanding	511.27	511.27	511.27	511.27	511.27	509.74
Total Common Shares Outstanding	511.27	511.27	511.27	511.27	511.27	509.74
Working Capital	28.9	30.67	6.5	4.05	5.17	1.31
Book Value Per Share	0.48	0.48	0.47	0.45	0.42	0.39
Tangible Book Value	178.5	185.52	186.09	179.6	165.91	151.98
Tangible Book Value Per Share	0.35	0.36	0.36	0.35	0.32	0.30
Land	25.34	25.5	35.39	31.9	29.28	27.58
Buildings	119.17	118.3	120.63	111.2	107.26	104.78
Machinery	143.73	140.12	134.1	128.6	120.64	115.91
Construction In Progress	8.76	6.48	5.6	4.85	4.33	1.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.